Invitrogen Corporation v. General Electric Company et al, No. 6:08-cv-00113 (E.D. Tex. Feb. 9, 2009)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is Defe ndants General Electric Company d.b.a. GE H ealthcare and GE Healthcare Bio-Scinces Corp.’s (collectively “GE”) Motion to Transfer Venue, (Doc. No. 30), Reply in Support, (Doc. No. 37), and Plaintiff Invitrogen Corp.’s (“Invitrogen”) Response, (Doc. No. 35). For the reasons stated below, Defendant’s Motion is DENIED. BACKGROUND Invitrogen is a De laware cor poration, with its principal place of business in Carlsbad, California a nd manufa cturing and distri bution fac ilities loca ted in Fr ederick, Mary land.